FDA clears SMV’s coincidence detection
Nuclear medicine vendor SMV America has received 510(k) clearance from the Food and Drug Administration for its Volumetric Coincidence Reconstruction (VCR) technique for its Vision FX-80 gamma camera. SMV, of Twinsburg, OH, joins ADAC Laboratories and
Nuclear medicine vendor SMV America has received 510(k) clearance from the Food and Drug Administration for its Volumetric Coincidence Reconstruction (VCR) technique for its Vision FX-80 gamma camera. SMV, of Twinsburg, OH, joins ADAC Laboratories and Picker International in the group of vendors that have 510(k) clearance for a coincidence-detection technique.
In other SMV America news, the company reported record growth in both orders and product sales for the fourth quarter of 1996, although as a private company it did not release specific dollar figures. The company said that camera and computer orders were up 189%, and shipment revenues increased 64% compared with the same period the year before. For the year, SMV said that product revenues grew by 30% and orders doubled.
SMV America ended the year with a 15.5% market share and a large backlog, the company said, while SMV International, its sister company, saw its market share in Europe expand to 25%.
Meta-Analysis Shows Merits of AI with CTA Detection of Coronary Artery Stenosis and Calcified Plaque
April 16th 2025Artificial intelligence demonstrated higher AUC, sensitivity, and specificity than radiologists for detecting coronary artery stenosis > 50 percent on computed tomography angiography (CTA), according to a new 17-study meta-analysis.
The Reading Room: Racial and Ethnic Minorities, Cancer Screenings, and COVID-19
November 3rd 2020In this podcast episode, Dr. Shalom Kalnicki, from Montefiore and Albert Einstein College of Medicine, discusses the disparities minority patients face with cancer screenings and what can be done to increase access during the pandemic.
Could Lymph Node Distribution Patterns on CT Improve Staging for Colon Cancer?
April 11th 2025For patients with microsatellite instability-high colon cancer, distribution-based clinical lymph node staging (dCN) with computed tomography (CT) offered nearly double the accuracy rate of clinical lymph node staging in a recent study.
